cbdmd.com (YCBD) Company Sales Revenue

Corporate emblem and logo of cbdMD Inc. (YCBD)

By optimizing distribution through online channels during a market downturn, cbdMD, Inc. (YCBD) is actively recruiting digital marketers and creative managers. The company's product sales trend clearly demonstrates daily revenue, where the current metric equals 0.02. Superior formulation purity and athlete trust allow the brand to maintain a dominant position in the retail segment of the wellness industry.

Revenue and Sales Volume: cbdMD, Inc. (YCBD) for 07/04/2022 - 11/14/2026

Analytical breakdowns for cbdMD, Inc.

- market price and analyst price targets:
- market capitalization details:
Summary company analysis:cbdmd.com YCBD
Product sample of cbdMD, Inc.

This indicator measures the aggregate cash flow from product sales, reflecting market demand dynamics and the effectiveness of the issuer's commercial strategy. When analyzing the operational sales of cbdMD, Inc. (YCBD), investors should correlate peaks and troughs with the industry cycle phase, noting that the full outsourcing model for production and logistics used by cbdMD, Inc. (YCBD) shifts the valuation focus from manufacturing capacity to marketing and design efficiency.

Competing companies

Company Total Revenue Haleon Corp HLN|Company Revenue Kenvue Inc. (KVUE)|VRNA (veronapharma.com) - Company Sales Revenue|Revenue and Sales Volume MENS (Jyong Biotech)|LGND - Company Sales|Amneal Pharmaceuticals Inc - Revenue and Sales Volume|PRGO: Company Revenue|ALVO: Revenue and Sales Volume|Company Sales Volume LQDA|Company Revenue Galapagos|Company Sales ANI Pharmaceuticals Inc (ANIP)|Revenue and Sales Volume MNKD|Amphastar Corp - Company Sales Volume|Pacira BioSciences - Company Sales|Company Sales Revenue SPRY|Theravance Biopharma, Inc. - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics Inc AQST|scpharmaceuticals.com (SCPH) - Company Revenue|Company Sales Volume TECX|TNXP (Tonix Pharmaceuticals) - Revenue and Sales Volume|Company Sales SXT China (SXTC)|Company Sales EPRX (Eupraxia Pharmaceuticals)|Company Gross Revenue BioHarvest Sciences, Inc.|Invizyne Technologies, Inc. - Company Sales|Oramed (ORMP) - Company Total Revenue|Entera Bio Corp - Revenue and Sales Volume|ipatherapeutics.com (HYFT) - Company Sales|ABVC: Revenue and Sales Volume|CPIX (Cumberland Pharmaceuticals Inc) - Company Revenue|QNTM (Quantum BioPharma Limited) - Revenue and Sales Volume|Company Sales Volume FGEN (FibroGen Corporation)|Company Revenue Telomir Pharmaceuticals (TELO)|RANI: Company Annual Revenue|Revenue and Sales Volume SNYR (Synergy CHC)|Company Sales Revenue RLYB|Lexaria - Revenue and Sales Volume|PULM - Revenue and Sales Volume|ftzy.com.cn (PTHL) - Company Revenue|Aptorum Group - Company Sales Revenue|Company Revenue Lyra Therapeutics|Company Sales impactbiomedinc.com (IBO)|Revenue and Sales Volume TNFA|Revenue and Sales Volume PainReform Corp (PRFX)|Altamira Therapeutics Ltd. - Company Sales|Company Sales Revenue LIPO|OPTN - Company Revenue|Company Total Revenue Pieris Pharmaceuticals Inc|PROC (Procaps Group SA) - Company Sales|PTPI: Company Total Sales|QLI (Qilian International) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP